PUBLISHER: The Business Research Company | PRODUCT CODE: 1760457
PUBLISHER: The Business Research Company | PRODUCT CODE: 1760457
An annuloplasty system is a medical device utilized in heart valve repair surgeries, primarily to treat valve dysfunction. It consists of a ring or band that is placed around the heart valve annulus to reshape or strengthen it, ensuring the valve closes properly. This device helps restore normal valve function and prevents the backward flow of blood within the heart, thereby enhancing heart performance and patient outcomes.
The main types of annuloplasty systems include annular rings and bands, as well as suture annuloplasty devices. Annular rings and bands are implantable devices used in heart valve repair surgeries, especially during annuloplasty procedures. These procedures may be performed via open-heart surgery, minimally invasive techniques, or robot-assisted methods. Annuloplasty systems are applied to various heart valves, including the mitral, tricuspid, aortic, and pulmonary valves, serving end users such as hospitals, ambulatory surgical centers, and cardiac care facilities.
The annuloplasty system market research report is one of a series of new reports from The Business Research Company that provides annuloplasty system market statistics, including annuloplasty system industry global market size, regional shares, competitors with a annuloplasty system market share, detailed annuloplasty system market segments, market trends and opportunities, and any further data you may need to thrive in the annuloplasty system industry. This annuloplasty system market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The annuloplasty system market size has grown strongly in recent years. It will grow from $0.65 billion in 2024 to $0.70 billion in 2025 at a compound annual growth rate (CAGR) of 7.3%. The growth during the historic period can be attributed to an increasing aging population, a rising prevalence of valvular heart diseases, greater adoption of minimally invasive surgical techniques, increased healthcare spending, and the expansion of cardiovascular specialty centers.
The annuloplasty system market size is expected to see strong growth in the next few years. It will grow to $0.92 billion in 2029 at a compound annual growth rate (CAGR) of 7.0%. The growth in the forecast period can be attributed to the increasing adoption of minimally invasive techniques, the expansion of transcatheter annuloplasty procedures, the rising global prevalence of cardiovascular diseases, growing demand for personalized medicine, and ongoing research advancements in biomaterials. Key trends during the forecast period include the integration of artificial intelligence in surgical planning, the development of bioabsorbable annuloplasty rings, the rise of robotic-assisted heart valve repairs, the increased use of three-dimensional (3D) printing for customized implants, and a greater focus on outpatient cardiac procedures.
The rising prevalence of cardiovascular diseases is expected to drive growth in the annuloplasty system market in the future. Cardiovascular diseases encompass a range of disorders affecting the heart and blood vessels, including coronary heart disease, heart failure, stroke, and hypertension. This increase is largely attributed to the aging population, as the natural wear and tear on the heart and blood vessels with age raises the risk of heart conditions. Annuloplasty systems assist in treating cardiovascular diseases by offering effective solutions for heart valve repair, restoring proper valve function, and improving blood flow. These systems improve patient outcomes by providing minimally invasive options for valve restoration, which reduces recovery time and lowers surgical risks. For example, in December 2023, the Australian Institute of Health and Welfare, a government agency in Australia, reported that doctor-certified deaths from coronary heart disease (CHD) increased from 14,100 in 2021 to 14,900 in 2022. Hence, the growing prevalence of cardiovascular diseases is fueling the growth of the annuloplasty system market.
Leading companies in the annuloplasty system market are focusing on developing innovative products such as next-generation surgical valves and devices to improve procedural efficiency and long-term patient outcomes. These next-generation surgical valves and devices are advanced medical technologies designed to simplify implantation, reduce surgical complexity, and enhance the precision and durability of valve repairs or replacements. For instance, in June 2024, Medtronic plc, a US-based medical technology firm, introduced the Avalus Ultra valve, a next-generation surgical aortic tissue valve. This device facilitates easier implantation with its low-profile valve holder and durable polyetheretherketone (PEEK) base frame, improving surgical ease and long-term functionality. It also enhances blood flow dynamics and offers visibility for future valve-in-valve procedures.
In July 2024, Affluent Medical SAS, a medical device company based in France, acquired Edwards Lifesciences Corporation for $16.3 million. This acquisition aims to expand Affluent Medical's presence in the cardiovascular market by strengthening its portfolio of heart valve solutions. It aligns with the company's strategic goal to accelerate the development of advanced therapies for heart disease and improve patient outcomes. Edwards Lifesciences is a US-based medical technology company specializing in annuloplasty systems for mitral and tricuspid valve repair to support heart valve restoration.
Major players in the annuloplasty system market are Abbott Laboratories, Medtronic PLC, Becton Dickinson and Company, Boston Scientific Corporation, B. Braun Mesungen AG, Terumo Corporation, Edwards Lifesciences Corporation, LivaNova PLC, MicroPort Scientific Corporation, B.Braile Biomedica, Affluent Medical, Micro Interventional Devices Inc., NeoChord Inc., Labcor Laboratories Ltd., BioVentrix Inc., CryoLife Inc., Genesse BioMedical, BioStable Science & Engineering Inc., FOC Medical S.A, and Cardiac Implants LLC.
North America was the largest region in the annuloplasty system market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in annuloplasty system report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the annuloplasty system market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The annuloplasty system market consists of sales of flexible annuloplasty rings, rigid annuloplasty rings, semi-rigid rings, adjustable bands, surgical tools, implantable devices, and associated accessories used in heart valve repair procedures. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Annuloplasty System Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on annuloplasty system market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for annuloplasty system ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The annuloplasty system market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.